March 25, 2021
2 mins read

EU revises vaccine export system

The principle of reciprocity will be applied to non-EU countries having at their disposal a large production capacity…reports Asian Lite News.

The European Commission presented a revised version of its export transparency mechanism for Covid-19 vaccines, with Executive Vice President Valdis Dombrovskis claiming that it does not constitute an export ban.

The mechanism takes aim at vaccines produced in European Union (EU)-based facilities of pharmaceutical companies that are bound by an advance purchase agreement (APA) with the EU. The new version includes two new criteria — reciprocity and proportionality — for assessing whether these vaccines can be exported to non-EU countries, according to Dombrovskis, Xinhua news agency reported on Wednesday.

The principle of reciprocity will be applied to non-EU countries having at their disposal a large production capacity. The European Commission and the EU member states will examine if the flow of imports and exports of vaccine and vaccine substances between the bloc and destination country is even.

Proportionality is about finding the right balance, the commissioner explained. The European Commission and the member states will take into account the specific situation of the country of destination, including its vaccination rate and the existing availability of Covid-19 vaccines.

AstraZeneca vaccine

Vaccine exports towards low- and middle-income countries covered by the COVAX (Covid-19 Vaccines Global Access) facility remain exempted.

Put in place on January 30, the export and transparency mechanism was launched when the EU argued that some pharmaceutical companies failed to honor their commitments to deliver the promised amount of doses to the EU countries but still could export vaccines from their EU-based facilities.

Originally due to expire on March 12, the mechanism has been extended until June 30.

(Photo: Pallav Paliwal)

A total of 381 export requests have been introduced by pharmaceutical companies bound by an APA with the EU, and only one has been declined.

AstraZeneca, a British-Swedish vaccine manufacturer, had applied to export 250,000 doses of its Covid-19 vaccine to Australia, while falling behind its delivery schedule for the EU.

“I remind you that AstraZeneca has only delivered a small portion of its agreed contractual commitments,” Dombrovskis said.

Also Read-EU leaders summit turns digital

Read More-EU sanctions China over Uighur abuses

Previous Story

Germany cancels plan for Easter lockdown

Next Story

Russia asks NATO to deal own problems

Latest from -Top News

India-EU Trade Talks Resume

The proposed India-EU FTA covers 23 policy areas, or chapters, of which at least two – market access and rules of origin – have yet to be resolved….reports Asian Lite News India

India Launches Relief Ops in Bhutan

The Royal Government of Bhutan has expressed sincere gratitude to the Indian Army…reports Asian Lite News Amid unprecedented floods caused by a low-pressure system over the Bay of Bengal, relentless rainfall has

Jaishankar Hints at Tariff Deal with US

Jaishankar explained that the ongoing trade tensions largely stem from the inability of both sides to reach a common ground on several issues….reports Asian Lite News External Affairs Minister S. Jaishankar on
Go toTop

Don't Miss

Global Covid caseload tops 491.3 mn

The global coronavirus caseload has topped 491.3 million, while the

G7: Boris to set end-2022 target to vaccinate world

The summit, starting on Friday, is the first between G7